Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S2.22
P/E—
Fwd P/E14.34
PEG1.41
52W— – —
RSI—
Target$19.5 (+9.7%)
Beta0.43
Div4.67%
Loading chart…
RSI ()
Loading patterns…
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 32
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
5Bullish
6Bearish
0Neutral
Key Signals 1
▼ Double Top
Major reversal
2026-09-08 · $18.48
Two peaks ~$19.57 — bearish reversal confirmed
Learn more →
Momentum Signals 10
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ Bull Flag
▲ MACD Bullish Crossover
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
88%
7/8 quarters
Wall Street Consensus
HOLD
BuyHoldSell
Price Target Range
$19.5
+9.7% upside
Low $18
—
High $23
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
58.44%Last 12 Months
Operating Margin
19.42%Last 12 Months
Return on Equity
15.58%Last 12 Months
Revenue Growth
3.00%Year over Year
Free Cash Flow
1.91BLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
81.62Most Recent Quarter
Current Ratio
1.00Most Recent Quarter
Cash
1.11BMost Recent Quarter
Total Debt
8.61BMost Recent Quarter
Net Debt
—Most Recent Quarter
How KVUE Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 34.15B |
| Enterprise Value | 41.65B |
| Trailing P/E | 20.92 |
| Forward P/E | 14.34 |
| PEG Ratio (5yr) | 1.41 |
| Price/Sales (ttm) | 2.22 |
| Price/Book (mrq) | 3.24 |
| EV/Revenue | 2.70 |
| EV/EBITDA | 11.97 |
Share Statistics
| Avg Vol (3m) | 21.42M |
| Shares Outstanding | 1.92B |
| Float | 1.92B |
| % Held by Insiders | 0.07% |
| % Held by Institutions | 95.91% |
| Short Ratio | 3.40 |
| Short % of Float | 4.35% |
Profitability
| Gross Margin | 58.44% |
| Operating Margin (ttm) | 19.42% |
| Profit Margin | 10.76% |
| Return on Assets (ttm) | 6.99% |
| Return on Equity (ttm) | 15.58% |
Income Statement
| Revenue (ttm) | 15.41B |
| Revenue Growth (yoy) | 3.00% |
| Gross Profit (ttm) | 9.00B |
| EBITDA | 3.48B |
| Net Income (ttm) | 1.66B |
| Diluted EPS (ttm) | 0.85 |
| EPS Growth (yoy) | 8.50% |
Balance Sheet
| Total Cash (mrq) | 1.11B |
| Total Debt (mrq) | 8.61B |
| Debt / Equity (mrq) | 81.62 |
| Current Ratio (mrq) | 1.00 |
| Book Value / Share | 5.50 |
| Operating CF (ttm) | 2.32B |
| Free Cash Flow (ttm) | 1.91B |
Trading & Dividends
| Beta (5Y) | 0.43 |
| 50-Day MA | 19.11 |
| 200-Day MA | 17.98 |
| Fwd Dividend Yield | 4.72% |
| Payout Ratio | 97.65% |
Income
Dividend Yield
4.67%Last 12 Months
Annual Rate
0.84Forward
Payout Ratio
97.65%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 97.65%
Monthly Dividends
Ownership Breakdown
Institutional 95.91%
Insider 0.07%
Public 4.0%
Short Interest
4.35% of float
Moderate
Institutional 13F Holdings
Famous investors who disclosed a position in KVUE in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|